{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:29:48Z","timestamp":1793723388438,"version":"4.6.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s11060-017-2573-y","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T11:40:59Z","timestamp":1500464459000},"page":"285-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?"],"prefix":"10.1007","volume":"135","author":[{"name":"On the Behalf of the\u00a0Club de Neuro-Oncologie of the Soci\u00e9t\u00e9 Fran\u00e7aise de Neurochirurgie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Zanello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Ursu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bauchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Guyotat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Jean","family":"Le Reste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Faillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Litre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Desse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Peltier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Voirin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Caire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Barat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Rodolphe","family":"Vignes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Menei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Dezamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phong","family":"Dam Hieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Metellus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-9844","authenticated-orcid":false,"given":"Johan","family":"Pallud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"issue":"Suppl 4","key":"2573_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J et al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012. Neuro-Oncol 17 Suppl 4:iv1\u2013iv62. doi: 10.1093\/neuonc\/nov189","journal-title":"Neuro-Oncol"},{"key":"2573_CR2","first-page":"1","volume":"9","author":"SL Colby","year":"2015","unstructured":"Colby SL, Ortman JM et al (2015) Projections of the size and composition of the US population: 2014 to 2060. Curr Popul Rep 9:1\u201313","journal-title":"Curr Popul Rep"},{"key":"2573_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1750-3639.2011.00491.x","volume":"21","author":"V Rigau","year":"2011","unstructured":"Rigau V, Zouaoui S, Mathieu-Daud\u00e9 H et al (2011) French brain tumor DataBase: 5-year histological results on 25 756 cases. Brain Pathol 21:633\u2013644. doi: 10.1111\/j.1750-3639.2011.00491.x","journal-title":"Brain Pathol"},{"key":"2573_CR4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/85.9.704","volume":"85","author":"WJ Curran","year":"1993","unstructured":"Curran WJ, Scott CB, Horton J et al (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704\u2013710","journal-title":"J Natl Cancer Inst"},{"key":"2573_CR5","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1200\/JCO.2005.04.5963","volume":"24","author":"R-O Mirimanoff","year":"2006","unstructured":"Mirimanoff R-O, Gorlia T, Mason W et al (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981\/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 24:2563\u20132569. doi: 10.1200\/JCO.2005.04.5963","journal-title":"J Clin Oncol"},{"key":"2573_CR6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/1471-2407-13-402","volume":"13","author":"SR Michaelsen","year":"2013","unstructured":"Michaelsen SR, Christensen IJ, Grunnet K et al (2013) Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution. BMC Cancer 13:402. doi: 10.1186\/1471-2407-13-402","journal-title":"BMC Cancer"},{"key":"2573_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10143-014-0528-8","volume":"37","author":"S Zouaoui","year":"2014","unstructured":"Zouaoui S, Darlix A, Fabbro-Peray P et al (2014) Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France. Neurosurg Rev 37:415\u2013424. doi: 10.1007\/s10143-014-0528-8","journal-title":"Neurosurg Rev"},{"key":"2573_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00701-002-1030-6","volume":"145","author":"V Vuorinen","year":"2003","unstructured":"Vuorinen V, Hinkka S, F\u00e4rkkil\u00e4 M, J\u00e4\u00e4skel\u00e4inen J (2003) Debulking or biopsy of malignant glioma in elderly people\u2014a randomised study. Acta Neurochir (Wien) 145:5\u201310. doi: 10.1007\/s00701-002-1030-6","journal-title":"Acta Neurochir (Wien)"},{"key":"2573_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1245\/s10434-010-1242-6","volume":"18","author":"KL Chaichana","year":"2011","unstructured":"Chaichana KL, Garzon-Muvdi T, Parker S et al (2011) Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann Surg Oncol 18:239\u2013245. doi: 10.1245\/s10434-010-1242-6","journal-title":"Ann Surg Oncol"},{"key":"2573_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/neuonc\/nor005","volume":"13","author":"JG Scott","year":"2011","unstructured":"Scott JG, Suh JH, Elson P et al (2011) Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro-Oncol 13:428\u2013436. doi: 10.1093\/neuonc\/nor005","journal-title":"Neuro-Oncol"},{"key":"2573_CR11","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1056\/NEJMoa065901","volume":"356","author":"F Keime-Guibert","year":"2007","unstructured":"Keime-Guibert F, Chinot O, Taillandier L et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527\u20131535. doi: 10.1056\/NEJMoa065901","journal-title":"N Engl J Med"},{"key":"2573_CR12","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1200\/JCO.2011.34.8086","volume":"29","author":"J G\u00e1llego P\u00e9rez-Larraya","year":"2011","unstructured":"G\u00e1llego P\u00e9rez-Larraya J, Ducray F, Chinot O et al (2011) Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. J Clin Oncol 29:3050\u20133055. doi: 10.1200\/JCO.2011.34.8086","journal-title":"J Clin Oncol"},{"key":"2573_CR13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. doi: 10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"2573_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou209.16","author":"JR Perry","year":"2016","unstructured":"Perry JR, Laperriere N, O\u2019Callaghan CJ et al (2016) A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (CCTG CE.6, EORTC 26062\u201322061, TROG 08.02, NCT00482677). J Clin Oncol. doi: 10.1093\/neuonc\/nou209.16","journal-title":"J Clin Oncol"},{"key":"2573_CR15","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/ana.21521","volume":"64","author":"FM Iwamoto","year":"2008","unstructured":"Iwamoto FM, Reiner AS, Panageas KS et al (2008) Patterns of care in elderly glioblastoma patients. Ann Neurol 64:628\u2013634. doi: 10.1002\/ana.21521","journal-title":"Ann Neurol"},{"key":"2573_CR16","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/neuonc\/nou063","volume":"16","author":"L Bauchet","year":"2014","unstructured":"Bauchet L, Zouaoui S, Darlix A et al (2014) Assessment and treatment relevance in elderly glioblastoma patients. Neuro-Oncol 16:1459\u20131468. doi: 10.1093\/neuonc\/nou063","journal-title":"Neuro-Oncol"},{"key":"2573_CR17","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.3747\/co.24.3424","volume":"24","author":"ER Morgan","year":"2017","unstructured":"Morgan ER, Norman A, Laing K, Seal MD (2017) Treatment and outcomes for glioblastoma in elderly compared with non-elderly patients: a population-based study. Curr Oncol Tor Ont 24:e92\u2013e98. doi: 10.3747\/co.24.3424","journal-title":"Curr Oncol Tor Ont"},{"key":"2573_CR18","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ijrobp.2007.07.2368","volume":"70","author":"SE Combs","year":"2008","unstructured":"Combs SE, Wagner J, Bischof M et al (2008) Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant Temozolomide in elderly patients. Int J Radiat Oncol 70:987\u2013992. doi: 10.1016\/j.ijrobp.2007.07.2368","journal-title":"Int J Radiat Oncol"},{"key":"2573_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s11060-010-0429-9","volume":"103","author":"C Ewelt","year":"2011","unstructured":"Ewelt C, Goeppert M, Rapp M et al (2011) Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. J Neurooncol 103:611\u2013618. doi: 10.1007\/s11060-010-0429-9","journal-title":"J Neurooncol"},{"key":"2573_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.14791\/btrt.2014.2.2.69","volume":"2","author":"H-K Park","year":"2014","unstructured":"Park H-K, Koh Y-C, Song SW (2014) The clinico-oncologic outcomes of elderly patients with glioblastoma after surgical resection followed by concomitant chemo-radiotherapy. Brain Tumor Res Treat 2:69. doi: 10.14791\/btrt.2014.2.2.69","journal-title":"Brain Tumor Res Treat"},{"key":"2573_CR21","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3171\/2015.4.JNS142200","volume":"124","author":"R Babu","year":"2016","unstructured":"Babu R, Komisarow JM, Agarwal VJ et al (2016) Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. J Neurosurg 124:998\u20131007. doi: 10.3171\/2015.4.JNS142200","journal-title":"J Neurosurg"},{"key":"2573_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.0839","author":"CG Rusthoven","year":"2016","unstructured":"Rusthoven CG, Koshy M, Sher DJ et al (2016) Combined-modality therapy with radiation and chemotherapy for elderly patients with glioblastoma in the temozolomide era: a national cancer database analysis. JAMA Neurol. doi: 10.1001\/jamaneurol.2016.0839","journal-title":"JAMA Neurol"},{"key":"2573_CR23","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1200\/JCO.2016.34.15_suppl.2034","volume":"34","author":"J Huang","year":"2016","unstructured":"Huang J, Samson PP, Perkins SM et al (2016) Trends in utilization and impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the national cancer data base. J Clin Oncol 34:2034","journal-title":"J Clin Oncol"},{"key":"2573_CR24","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1200\/JCO.2016.34.15_suppl.2045","volume":"34","author":"M Martinez-Garcia","year":"2016","unstructured":"Martinez-Garcia M, Pineda E, Barco SD et al (2016) Feasibility and efficacy of concomitant chemoradiation (Ch-RT) in the management of newly diagnosed elderly glioblastoma (GB) patients: results from the GLIOCAT study. J Clin Oncol 34:2045","journal-title":"J Clin Oncol"},{"key":"2573_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30730","author":"MJ Amsbaugh","year":"2017","unstructured":"Amsbaugh MJ, Yusuf MB, Gaskins J et al (2017) Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: an analysis of the National Cancer Database. Cancer. doi: 10.1002\/cncr.30730","journal-title":"Cancer"},{"key":"2573_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyx148","author":"PM Flanigan","year":"2017","unstructured":"Flanigan PM, Jahangiri A, Kuang R et al (2017) Developing an algorithm for optimizing care of elderly patients with glioblastoma. Neurosurgery. doi: 10.1093\/neuros\/nyx148","journal-title":"Neurosurgery"},{"key":"2573_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/neuonc\/nos273","volume":"15","author":"M Weller","year":"2013","unstructured":"Weller M, Cloughesy T, Perry JR, Wick W (2013) Standards of care for treatment of recurrent glioblastoma\u2013are we there yet? Neuro-Oncol 15:4\u201327. doi: 10.1093\/neuonc\/nos273","journal-title":"Neuro-Oncol"},{"key":"2573_CR28","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR, Cascino TL, Schold SC, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277\u20131280","journal-title":"J Clin Oncol"},{"key":"2573_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ijrobp.2010.06.012","volume":"81","author":"J Li","year":"2011","unstructured":"Li J, Wang M, Won M et al (2011) Validation and simplification of the radiation therapy oncology group recursive partitioning analysis classification for glioblastoma. Int J Radiat Oncol 81:623\u2013630. doi: 10.1016\/j.ijrobp.2010.06.012","journal-title":"Int J Radiat Oncol"},{"key":"2573_CR30","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963\u20131972. doi: 10.1200\/JCO.2009.26.3541","journal-title":"J Clin Oncol"},{"key":"2573_CR31","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1200\/JCO.2013.51.8886","volume":"32","author":"NF Marko","year":"2014","unstructured":"Marko NF, Weil RJ, Schroeder JL et al (2014) Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. J Clin Oncol Off J Am Soc Clin Oncol 32:774\u2013782. doi: 10.1200\/JCO.2013.51.8886","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"Suppl 3","key":"2573_CR32","doi-asserted-by":"publisher","first-page":"iii93","DOI":"10.1093\/annonc\/mdu050","volume":"25","author":"R Stupp","year":"2014","unstructured":"Stupp R, Brada M, van den Bent MJ et al (2014) High-grade glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):iii93\u2013i101. doi: 10.1093\/annonc\/mdu050","journal-title":"Ann Oncol"},{"key":"2573_CR33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3747\/co.2007.119","volume":"14","author":"WP Mason","year":"2007","unstructured":"Mason WP, Maestro RD, Eisenstat D et al (2007) Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol Tor Ont 14:110\u2013117","journal-title":"Curr Oncol Tor Ont"},{"key":"2573_CR34","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.ctrv.2011.12.010","volume":"38","author":"C Chargari","year":"2012","unstructured":"Chargari C, Feuvret L, Bauduceau O et al (2012) Treatment of elderly patients with glioblastoma: from clinical evidence to molecular highlights. Cancer Treat Rev 38:988\u2013995. doi: 10.1016\/j.ctrv.2011.12.010","journal-title":"Cancer Treat Rev"},{"key":"2573_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00401-010-0781-z","volume":"120","author":"C Hartmann","year":"2010","unstructured":"Hartmann C, Hentschel B, Wick W et al (2010) Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol (Berl) 120:707\u2013718. doi: 10.1007\/s00401-010-0781-z","journal-title":"Acta Neuropathol (Berl)"},{"key":"2573_CR36","doi-asserted-by":"publisher","first-page":"e85102","DOI":"10.1371\/journal.pone.0085102","volume":"9","author":"A Yin","year":"2014","unstructured":"Yin A, Zhang L, Cheng J et al (2014) The predictive but not prognostic value of MGMT promoter methylation status in elderly glioblastoma patients: a meta-analysis. PLoS ONE 9:e85102. doi: 10.1371\/journal.pone.0085102","journal-title":"PLoS ONE"},{"key":"2573_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/neuonc\/nor019","volume":"13","author":"M Weller","year":"2011","unstructured":"Weller M, Wick W (2011) Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma? Neuro-Oncol 13:365\u2013366. doi: 10.1093\/neuonc\/nor019","journal-title":"Neuro-Oncol"},{"key":"2573_CR38","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","volume":"13","author":"W Wick","year":"2012","unstructured":"Wick W, Platten M, Meisner C et al (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13:707\u2013715. doi: 10.1016\/S1470-2045(12)70164-X","journal-title":"Lancet Oncol"},{"key":"2573_CR39","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0360-3016(98)00296-X","volume":"42","author":"DS Mohan","year":"1998","unstructured":"Mohan DS, Suh JH, Phan JL et al (1998) Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42:981\u2013987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2573_CR40","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00415-003-1036-x","volume":"250","author":"A Muacevic","year":"2003","unstructured":"Muacevic A, Kreth FW (2003) Quality-adjusted survival after tumor resection and\/or radiation therapy for elderly patients with glioblastoma multiforme. J Neurol 250:561\u2013568. doi: 10.1007\/s00415-003-1036-x","journal-title":"J Neurol"},{"key":"2573_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10143-006-0051-7","volume":"30","author":"AM Stark","year":"2007","unstructured":"Stark AM, Hedderich J, Held-Feindt J, Mehdorn HM (2007) Glioblastoma\u2013the consequences of advanced patient age on treatment and survival. Neurosurg Rev 30:56\u201361. doi: 10.1007\/s10143-006-0051-7","journal-title":"Neurosurg Rev"},{"key":"2573_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1215\/15228517-2007-038","volume":"10","author":"G Filippini","year":"2008","unstructured":"Filippini G, Falcone C, Boiardi A et al (2008) Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro-Oncol 10:79\u201387. doi: 10.1215\/15228517-2007-038","journal-title":"Neuro-Oncol"},{"key":"2573_CR43","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1002\/cncr.24413","volume":"115","author":"FM Iwamoto","year":"2009","unstructured":"Iwamoto FM, Cooper AR, Reiner AS et al (2009) Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center experience (1997\u20132007). Cancer 115:3758\u20133766. doi: 10.1002\/cncr.24413","journal-title":"Cancer"},{"key":"2573_CR44","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1200\/JCO.2015.62.6606","volume":"33","author":"W Roa","year":"2015","unstructured":"Roa W, Kepka L, Kumar N et al (2015) International atomic energy agency randomized phase III study of radiation therapy in elderly and\/or frail patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 33:4145\u20134150. doi: 10.1200\/JCO.2015.62.6606","journal-title":"J Clin Oncol"},{"key":"2573_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijrobp.2014.09.013","volume":"91","author":"G Minniti","year":"2015","unstructured":"Minniti G, Scaringi C, Lanzetta G et al (2015) Standard (60\u00a0Gy) or short-course (40\u00a0Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis. Int J Radiat Oncol 91:109\u2013115. doi: 10.1016\/j.ijrobp.2014.09.013","journal-title":"Int J Radiat Oncol"},{"key":"2573_CR46","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","volume":"13","author":"A Malmstr\u00f6m","year":"2012","unstructured":"Malmstr\u00f6m A, Gr\u00f8nberg BH, Marosi C et al (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 13:916\u2013926. doi: 10.1016\/S1470-2045(12)70265-6","journal-title":"Lancet Oncol"},{"key":"2573_CR47","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jocn.2014.09.018","volume":"22","author":"HR Kim","year":"2015","unstructured":"Kim HR, Kim KH, Kong D-S et al (2015) Outcome of salvage treatment for recurrent glioblastoma. J Clin Neurosci 22:468\u2013473. doi: 10.1016\/j.jocn.2014.09.018","journal-title":"J Clin Neurosci"},{"key":"2573_CR48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11060-015-1987-7","volume":"126","author":"J Socha","year":"2016","unstructured":"Socha J, Kepka L, Ghosh S et al (2016) Outcome of treatment of recurrent glioblastoma multiforme in elderly and\/or frail patients. J Neurooncol 126:493\u2013498. doi: 10.1007\/s11060-015-1987-7","journal-title":"J Neurooncol"},{"key":"2573_CR49","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1002\/cncr.27570","volume":"118","author":"JG Scott","year":"2012","unstructured":"Scott JG, Bauchet L, Fraum TJ et al (2012) Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer 118:5595\u20135600. doi: 10.1002\/cncr.27570","journal-title":"Cancer"},{"key":"2573_CR50","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3390\/cancers5031177","volume":"5","author":"LT Nguyen","year":"2013","unstructured":"Nguyen LT, Touch S, Nehme-Schuster H et al (2013) Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy. Cancers 5:1177\u20131198. doi: 10.3390\/cancers5031177","journal-title":"Cancers"},{"key":"2573_CR51","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","volume":"32","author":"H Wildiers","year":"2014","unstructured":"Wildiers H, Heeren P, Puts M et al (2014) International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32:2595\u20132603. doi: 10.1200\/JCO.2013.54.8347","journal-title":"J Clin Oncol"},{"key":"2573_CR52","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1093\/annonc\/mdq687","volume":"22","author":"AG Pallis","year":"2011","unstructured":"Pallis AG, Ring A, Fortpied C et al (2011) EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors. Ann Oncol 22:1922\u20131926. doi: 10.1093\/annonc\/mdq687","journal-title":"Ann Oncol"},{"key":"2573_CR53","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1200\/JCO.2013.55.0418","volume":"32","author":"A Hurria","year":"2014","unstructured":"Hurria A, Dale W, Mooney M et al (2014) Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. J Clin Oncol 32:2587\u20132594. doi: 10.1200\/JCO.2013.55.0418","journal-title":"J Clin Oncol"},{"key":"2573_CR54","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1200\/JCO.2010.30.0582","volume":"28","author":"JK Park","year":"2010","unstructured":"Park JK, Hodges T, Arko L et al (2010) Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol 28:3838\u20133843. doi: 10.1200\/JCO.2010.30.0582","journal-title":"J Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2573-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2573-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2573-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T19:54:58Z","timestamp":1569873298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2573-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["2573"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2573-y","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]}}}